食NMN补充剂可以增强ALS的运动和NMJ功能
Samuel Lundt1, Nannan Zhang2, Luis Polo-Parada3
1Interdisciplinary Neuroscience Program, University of Missouri, Columbia, MO 65211, United States of America; Dalton Cardiovascular Research Center, University of Missouri, Columbia, MO 65211, United States of America.
Experimental neurology
|January 24, 2024
概括
尼古丁胺胺单核酸 (NMN) 补充剂在肌缩性侧面硬化症 (ALS) 鼠标模型中适度延长寿命和延迟运动功能障碍. 在ALS小鼠中,NMN改善了神经肌肉结合功能和整体健康状况.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 代谢研究研究 代谢研究
背景情况:
- 肌缩侧面硬化症 (ALS) 是一种致命的神经退行性疾病,其特征是运动神经元损失.
- 尼古丁胺胺氨基二核酸 (NAD+) 对于细胞能量代谢和非代谢功能至关重要.
- 随着年龄的增长和各种疾病状态,NAD+水平下降.
研究的目的:
- 在ALS的小鼠模型中研究尼古丁胺胺单核酸 (NMN) 的治疗潜力,这是NAD+的前体.
- 评估食NMN补充对ALS小鼠疾病进展,寿命和神经肌肉结 (NMJ) 功能的影响.
主要方法:
- 使用了ALS的SOD1G93A小鼠模型.
- 通过饮食对ALS小鼠 (ALS+NMN) 进行NMN补充.
- 评估寿命,运动功能,神经肌肉结 (NMJ) 电生理学,形态学和脊髓病理学.
主要成果:
- 在ALS小鼠中,NMN补充剂适度延长了寿命和延迟了运动功能障碍.
- NMN改善了神经肌肉结 (NMJ) 功能,包括更大的终端板电位 (EPP) 幅度和恢复的EPP促进.
- NMN增强了NMJ形态,内化,线粒体结构,并减少了脊髓星.
结论:
- 食NMN补充剂在ALS小鼠模型中显示出减缓疾病进展和改善健康状况的前景.
- 通过增强NMJ功能和减轻神经炎症,NMN可能会产生有益的影响.
- 进一步研究NMN作为ALS潜在的治疗策略是有必要的.
相关概念视频
01:29Neuromuscular Junction And Blockade
3.1K
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
3.1K
01:19The Neuromuscular Junction
9.7K
The nervous system consists of complex motor neuron circuits, including upper motor neurons originating from the cerebral cortex and lower motor neurons starting in the spinal cord, coordinating both voluntary and involuntary movements. Among these, somatic motor neurons activate skeletal muscles and are classified into alpha, beta, and gamma types. Alpha neurons are vital for voluntary movement coordination, while gamma neurons adjust muscle spindle sensitivity, and the function of beta...
9.7K
01:15Myasthenia Gravis: Diagnostic Tests
844
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
844
01:20Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K